Filtered By:
Condition: Eczema
This page shows you your search results in order of date. This is page number 16.
Order by Relevance | Date
Total 2491 results found since Jan 2013.
Atopic Dermatitis Polypharmacy and Out-Of-Pocket Healthcare Expenses
CONCLUSION: Individuals with AD report considerable polypharmacy, which is associated with increased OOP expenses and harmful financial impact. Strategies are needed to reduce polypharmacy, minimize OOP costs, and optimize clinical outcomes. J Drugs Dermatol. 2023;22(2): doi:10.36849/JDD.7038.PMID:36745366 | DOI:10.36849/JDD.7038
Source: Journal of Drugs in Dermatology - February 6, 2023 Category: Dermatology Authors: Raj Chovatiya Wendy Smith Begolka Isabelle Thibau Jonathan Silverberg Source Type: research
Validated Anxiety Assessments Among Pediatric Peanut-Allergic Patients on Oral Immunotherapy
CONCLUSION: The clinical implications of these findings suggest that allergists should particularly consider screening food-allergic children for anxiety and anxiety-subtypes among patients who are non-white, female, and/or have asthma.PMID:36738780 | DOI:10.1016/j.anai.2023.01.028
Source: Annals of Allergy, Asthma and Immunology - February 4, 2023 Category: Allergy & Immunology Authors: Kelsey Kaman Meera Dhodapkar Veronika Shabanova Sarah McCollum Jeffrey Factor Stephanie Leeds Source Type: research
Time Trends in Atopic Dermatitis Incidence and Use of Skin Prick Tests and Oral Challenges Among Commercially Insured Infants in the United States, 2013-2020
We examined trends for atopic dermatitis (AD) incidence, skin prick testing (SPT), and oral challenge (OC) in a population of commercially insured infants in the U.S. from 2013 – 2020.
Source: Journal of Allergy and Clinical Immunology - February 1, 2023 Category: Allergy & Immunology Authors: Edward Iglesia, Leonard Bacharier, Stacie Dusetzina, Russell Rothman Source Type: research
Dupilumab-associated Angioedema in an Adult
Dupilumab is a relatively new monoclonal antibody which targets IL-4 and IL-13 for use in moderate to severe eczema, asthma, and nasal polyposis. To the authors knowledge, this is the first report of dupilumab associated angioedema in an adult.
Source: Journal of Allergy and Clinical Immunology - February 1, 2023 Category: Allergy & Immunology Authors: Trevor Hodson, Duane Wong Source Type: research
Low Levels of Carotenoids in Maternal Serum and Breast Milk Associate with the Development of Atopic Dermatitis in Infancy
Although it has been shown that maternal intake of vegetables during pregnancy was associated with a decrease in the odds of eczema, the association between maternal and infant carotenoid levels and the development of Atopic dermatitis (AD) in infancy is not clear.
Source: Journal of Allergy and Clinical Immunology - February 1, 2023 Category: Allergy & Immunology Authors: Yuzaburo Inoue, Yu Yamamoto, Shigenori Suzuki, Shingo Ochiai, Akifumi Eguchi, Taiji Nakano, Fumiya Yamaide, Satomi Hasegawa, Hiroyuki Kojima, Hiroko Suzuki, Chisato Mori, Yoichi Kohno, Masaru Taniguchi, Hiroyuki Suganuma, Naoki Shimojo Source Type: research
Demographic differences in self-reported barriers and facilitators to eczema clinical trial participation among adult patients and caregivers of pediatric patients.
Eczema clinical trials (eCTs) are increasing in number yet little is known about the association between participant demographics and their views on barriers and facilitators of clinical trial participation.
Source: Journal of Allergy and Clinical Immunology - February 1, 2023 Category: Allergy & Immunology Authors: Isabelle Thibau, Wenelia Baghoomian, Michael Jacobson, Ajai Kastala, Eric Simpson, Wendy Smith Begolka Source Type: research
